Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update

1d ago, source:

WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging ...

Arbutus Biopharma Wins Key Ruling in Patent Suit Against Moderna Over COVID-19 Vaccine Technology

12d ago, source: MyChesCo on MSN

Arbutus Biopharma Corporation recently announced a favorable outcome in its ongoing patent infringement lawsuit against ...

Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains

9d ago, source:

Arbutus Biopharma and Roivant's patent infringement lawsuit against Moderna takes a positive turn. Read why we remain on the sidelines of ABUS stock for now.

Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge

on MSN ago, source:

A Delaware District Court sided with Arbutus Biopharma Corporation (NASDAQ:ABUS) and Genevant Sciences in their ongoing patent infringement case against Moderna Inc (NASDAQ:MRNA) COVID-19 vaccine. The ...

Arbutus Biopharma Corp (NASDAQ: ABUS) Is Up 23.60% Year-To-Date, But There Is Speculation That It Will Rally

11d ago, source:

Arbutus Biopharma Corp (NASDAQ:ABUS) traded at $3.09 at close of the session on Monday, April 08, made a downward move of -0.96% on its previous day’s price. Looking at the stock we see that its ...

Arbutus Biopharma jumps after claim construction order in patent fight with Moderna

16d ago, source: Seeking Alpha

Arbutus Biopharma (NASDAQ:ABUS) quickly soared 19% after a claim construction order in a Covid vaccine patent dispute with Moderna (NASDAQ:MRNA) according to a court filing on Wednesday. Moderna fell ...

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

1d ago, source:

FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) ('Company'), a clinical-stage ...